Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen

A Maitra, T Munshi, J Healy, LT Martin… - FEMS microbiology …, 2019‏ - academic.oup.com
Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis,
remains one of the leading causes of mortality across the world. There is an urgent …

Tuberculosis drug discovery: A decade of hit assessment for defined targets

S Oh, L Trifonov, VD Yadav, CE Barry III… - Frontiers in Cellular …, 2021‏ - frontiersin.org
More than two decades have elapsed since the publication of the first genome sequence of
Mycobacterium tuberculosis (Mtb) which, shortly thereafter, enabled methods to determine …

Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular …

M Kumari, R Singh, N Subbarao - Journal of Biomolecular …, 2022‏ - Taylor & Francis
Multi-targeting enzyme approaches are considered to be the most significant in suppressing
pathogen growth and disease control for MDR and XDR-resistant Mycobacterium …

[HTML][HTML] An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis

M Imran, SA Khan, SMB Asdaq, M Almehmadi… - Journal of Infection and …, 2022‏ - Elsevier
Abstract Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1) inhibitors are an innovative
and futuristic orally active group of antituberculosis agents. A few DprE1 inhibitors are in the …

Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids

A Pawar, P Jha, M Chopra, U Chaudhry, D Saluja - Scientific reports, 2020‏ - nature.com
Tuberculosis (TB) is caused by Mycobacterium tuberculosis (MTB), a highly infectious
disease accounting for nearly 1.5 million deaths every year and has been a major global …

Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis—an enzyme involved in peptidoglycan biosynthesis

A Pawar, P Jha, C Konwar, U Chaudhry… - Applied microbiology …, 2019‏ - Springer
Increasing drug resistance in pathogens including Mycobacterium tuberculosis (MTB) has
been ascribed to mutations in the known target genes. However, many of these drugs have …

Moonlighting proteins: beacon of hope in era of drug resistance in bacteria

P Yadav, R Singh, S Sur, S Bansal… - Critical Reviews in …, 2023‏ - Taylor & Francis
Moonlighting proteins (MLPs) are ubiquitous and provide a unique advantage to bacteria
performing multiple functions using the same genomic content. Targeting MLPs can be …

Experimental evidence of d‐glutamate racemase activity in the uncultivated bacterium Candidatus Saccharimonas aalborgensis

M Peñalver, A Paradela… - Environmental …, 2024‏ - Wiley Online Library
Abstract The Candidate Phyla Radiation (CPR) encompasses widespread uncultivated
bacteria with reduced genomes and limited metabolic capacities. Most CPR bacteria lack …

Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis

GA Prosser, A Rodenburg, H Khoury… - Antimicrobial agents …, 2016‏ - journals.asm.org
The increasing global prevalence of drug resistance among many leading human
pathogens necessitates both the development of antibiotics with novel mechanisms of action …

Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors

P Malapati, VS Krishna, R Nallangi… - European Journal of …, 2018‏ - Elsevier
In the present study, we attempted to develop novel class of Mycobacterium tuberculosis
(Mtb) inhibitors by exploring the pharmaceutically underexploited enzyme targets which are …